Login to Your Account



BREAKING UP IS HARD TO DO

Abbvie to shell out a record $1.635B break-up fee to Shire

By Staff Reports


Tuesday, October 21, 2014
It's official. The board of directors at Dublin-based Shire plc agreed on Monday with Abbvie Inc. that its proposed $55 billion purchase of the Irish company is not going to happen. Now Abbvie must write a check for a $1.635 billion break-up fee.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription